1677 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 34 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
PRR11Proline rich 11Predicted intracellular proteins
Endoplasmic reticulumRenal cancer: 0.00e+0
Liver cancer: 1.35e-7
Lung cancer: 1.79e-4
Endometrial cancer: 1.90e-4
Pancreatic cancer: 6.18e-4
Mixed
PRR15LProline rich 15 likePredicted intracellular proteins
CytosolRenal cancer: 6.29e-13
Stomach cancer: 1.69e-5
Tissue enhanced
PRR19Proline rich 19Predicted intracellular proteins
Nucleus
Nucleoli
Nuclear bodies
Tissue enriched
PRR5LProline rich 5 likePredicted intracellular proteins
Cytokinetic bridge
Cytosol
Renal cancer: 7.71e-8
Endometrial cancer: 7.30e-5
Stomach cancer: 4.86e-4
Tissue enhanced
PRRG2Proline rich and Gla domain 2Predicted membrane proteins
Predicted secreted proteins
Nucleus
Nucleoli
Cytosol
Renal cancer: 3.82e-9
Mixed
PRRX2Paired related homeobox 2Predicted intracellular proteins
Transcription factors
Nucleoplasm
Nuclear bodies
Tissue enhanced
PSD3Pleckstrin and Sec7 domain containing 3Predicted intracellular proteins
Nucleus
Vesicles
Endometrial cancer: 5.76e-5
Colorectal cancer: 7.55e-4
Tissue enhanced
PSEN1Presenilin 1Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleus
Golgi apparatus
Cell Junctions
Renal cancer: 1.52e-8
Liver cancer: 1.99e-5
Expressed in all
PSMA3Proteasome subunit alpha 3Enzymes
Plasma proteins
Predicted intracellular proteins
Microtubules
Cytokinetic bridge
Thyroid cancer: 2.91e-4
Expressed in all
PSMB3Proteasome subunit beta 3Enzymes
Plasma proteins
Predicted intracellular proteins
MitochondriaRenal cancer: 1.71e-6
Expressed in all
PSMB6Proteasome subunit beta 6Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Cytosol
Renal cancer: 5.93e-4
Expressed in all
PSMB7Proteasome subunit beta 7Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Cytosol
Expressed in all
PSMB8Proteasome subunit beta 8Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Vesicles
Cytokinetic bridge
Breast cancer: 5.08e-4
Endometrial cancer: 7.16e-4
Mixed
PSMD3Proteasome 26S subunit, non-ATPase 3Predicted intracellular proteins
Nucleoplasm
Cytosol
Renal cancer: 4.47e-7
Expressed in all
PSMG1Proteasome assembly chaperone 1Predicted intracellular proteins
Nucleoplasm
Golgi apparatus
Cytosol
Renal cancer: 3.58e-5
Expressed in all
PSMG4Proteasome assembly chaperone 4Predicted intracellular proteins
Nucleus
Mitochondria
Renal cancer: 7.45e-4
Expressed in all
PSPC1Paraspeckle component 1Predicted intracellular proteins
Transcription factors
Nucleoplasm
Nucleoli fibrillar center
Thyroid cancer: 1.46e-4
Liver cancer: 2.21e-4
Expressed in all
PSTKPhosphoseryl-tRNA kinaseEnzymes
Predicted intracellular proteins
Nucleoli
Nuclear bodies
Actin filaments
Mixed
PTGESProstaglandin E synthaseEnzymes
Predicted membrane proteins
Endoplasmic reticulumPancreatic cancer: 7.97e-5
Colorectal cancer: 2.32e-4
Tissue enhanced
PTGES2Prostaglandin E synthase 2Enzymes
Predicted intracellular proteins
MitochondriaRenal cancer: 5.83e-7
Expressed in all
PTGS2Prostaglandin-endoperoxide synthase 2Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Endoplasmic reticulumRenal cancer: 9.79e-4
Tissue enhanced
PTOV1Prostate tumor overexpressed 1Predicted intracellular proteins
NucleusColorectal cancer: 6.64e-4
Pancreatic cancer: 9.20e-4
Expressed in all
PTPN11Protein tyrosine phosphatase, non-receptor type 11Cancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nucleus
Nucleoli
Actin filaments
Cytosol
Expressed in all
PTPRQProtein tyrosine phosphatase, receptor type QPredicted intracellular proteins
Predicted membrane proteins
CytosolTissue enhanced
PUS10Pseudouridylate synthase 10Enzymes
Predicted intracellular proteins
Nucleoplasm
Nuclear bodies
Mitochondria
Mixed
PUSL1Pseudouridylate synthase-like 1Predicted intracellular proteins
VesiclesRenal cancer: 1.62e-5
Liver cancer: 1.33e-4
Expressed in all
PVALBParvalbuminPredicted intracellular proteins
Nucleoplasm
Nucleoli
Cell Junctions
Tissue enriched
PWP1PWP1 homolog, endonucleinPredicted intracellular proteins
Nucleoli
Golgi apparatus
Liver cancer: 1.40e-5
Renal cancer: 2.26e-4
Head and neck cancer: 9.65e-4
Expressed in all
PYGBGlycogen phosphorylase BCandidate cardiovascular disease genes
Enzymes
Plasma proteins
Predicted intracellular proteins
CytosolLung cancer: 1.10e-4
Urothelial cancer: 1.43e-4
Liver cancer: 4.37e-4
Expressed in all
PYGO2Pygopus family PHD finger 2Predicted intracellular proteins
NucleoplasmLiver cancer: 3.88e-6
Urothelial cancer: 1.76e-4
Expressed in all
PYM1PYM homolog 1, exon junction complex associated factorPredicted intracellular proteins
Nucleus
Nucleoli
Cell Junctions
Cytosol
Urothelial cancer: 1.34e-4
Liver cancer: 3.05e-4
Expressed in all
QARSGlutaminyl-tRNA synthetaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
CytosolRenal cancer: 5.60e-6
Breast cancer: 1.43e-4
Expressed in all
QPCTLGlutaminyl-peptide cyclotransferase likeEnzymes
Predicted intracellular proteins
Golgi apparatusRenal cancer: 2.15e-8
Mixed
R3HCC1R3H domain and coiled-coil containing 1Predicted intracellular proteins
Nucleoplasm
Cytosol
Renal cancer: 6.80e-5
Colorectal cancer: 4.08e-4
Pancreatic cancer: 8.66e-4
Expressed in all
RAB11FIP1RAB11 family interacting protein 1Predicted intracellular proteins
VesiclesRenal cancer: 1.14e-6
Head and neck cancer: 6.61e-4
Expressed in all
RAB11FIP3RAB11 family interacting protein 3Cancer-related genes
Predicted intracellular proteins
Vesicles
Cytokinetic bridge
Microtubule organizing center
Pancreatic cancer: 3.16e-5
Liver cancer: 9.87e-5
Endometrial cancer: 1.22e-4
Renal cancer: 7.99e-4
Expressed in all
RAB24RAB24, member RAS oncogene familyPredicted intracellular proteins
Focal adhesion sitesRenal cancer: 2.54e-7
Liver cancer: 7.56e-5
Head and neck cancer: 6.22e-4
Expressed in all
RAB26RAB26, member RAS oncogene familyPredicted intracellular proteins
Predicted secreted proteins
Vesicles
Plasma membrane
Centrosome
Cervical cancer: 8.20e-5
Tissue enhanced
RAB29RAB29, member RAS oncogene familyPredicted intracellular proteins
Nuclear membrane
Nucleoli
Endometrial cancer: 1.82e-5
Liver cancer: 1.61e-4
Expressed in all
RAB3IPRAB3A interacting proteinPredicted intracellular proteins
Intermediate filamentsRenal cancer: 5.68e-13
Tissue enhanced
RAB5BRAB5B, member RAS oncogene familyPredicted intracellular proteins
RAS pathway related proteins
VesiclesBreast cancer: 2.24e-5
Expressed in all
RAB8ARAB8A, member RAS oncogene familyPredicted intracellular proteins
Nucleus
Plasma membrane
Renal cancer: 6.56e-5
Thyroid cancer: 1.71e-4
Expressed in all
RAB8BRAB8B, member RAS oncogene familyPredicted intracellular proteins
Nucleoplasm
Vesicles
Renal cancer: 2.44e-4
Expressed in all
RABGAP1LRAB GTPase activating protein 1 likePredicted intracellular proteins
Predicted membrane proteins
Nucleoli
Cytosol
Lung cancer: 1.16e-4
Expressed in all
RABL6RAB, member RAS oncogene family-like 6Predicted intracellular proteins
Centrosome
Cytosol
Pancreatic cancer: 1.46e-4
Endometrial cancer: 4.00e-4
Stomach cancer: 9.14e-4
Expressed in all
RACGAP1Rac GTPase activating protein 1Predicted intracellular proteins
NucleoplasmRenal cancer: 3.98e-8
Liver cancer: 1.86e-6
Pancreatic cancer: 4.12e-6
Breast cancer: 1.51e-4
Tissue enhanced
RAD51AP1RAD51 associated protein 1Predicted intracellular proteins
NucleusRenal cancer: 4.44e-15
Pancreatic cancer: 1.22e-5
Liver cancer: 3.53e-4
Endometrial cancer: 9.42e-4
Mixed
RAD51CRAD51 paralog CDisease related genes
Predicted intracellular proteins
Nucleus
Vesicles
Cell Junctions
Mitochondria
Cytosol
Liver cancer: 8.68e-5
Pancreatic cancer: 5.33e-4
Expressed in all
RAG1Recombination activating 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
NucleusTissue enhanced
RAMP1Receptor activity modifying protein 1FDA approved drug targets
Predicted membrane proteins
Nucleoplasm
Nuclear membrane
Stomach cancer: 1.68e-4
Liver cancer: 7.61e-4
Tissue enhanced
« prev | Page of 34 | next »